LENSAR, Inc.
NASDAQ:LNSR · NASDAQ Capital Market
-$0.51 today
Vol 0.10M · Avg 0.09M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-53.10%
Period High
$13.32
Period Low
$5.09
Latest
$5.74
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Anteris Technologies Global Corp.
NASDAQ:AVR
$349.12M
Profound Medical Corp.
NASDAQ:PROF
$205.46M
Anika Therapeutics, Inc.
NASDAQ:ANIK
$188.54M
TriSalus Life Sciences, Inc.
NASDAQ:TLSI
$149.56M
MaxCyte, Inc.
NASDAQ:MXCT
$126.94M
Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBP
$103.29M
Owlet, Inc.
NYSE:OWLT
$92.64M
Cardiff Oncology, Inc.
NASDAQ:CRDF
$82.73M
Rapid Micro Biosystems, Inc.
NASDAQ:RPID
$77.27M
Accuray Incorporated
ARAY
$40.59M
What is the latest LNSR filing?
The latest filing shown is 4 dated Jun 5, 2026.
How many recent filings does LNSR have?
Intrinsic Alpha currently shows 20 recent filings for LNSR.
Explore More
Continue the stock analysis
Jump to another research area for this company.